AI Article Synopsis

  • The study analyzed the Sanhan Huashi Formula's active components using advanced mass spectrometry techniques, helping to understand its pharmacological basis.
  • 308 major chemical components were identified, including key groups like alkaloids and flavonoids, with 60 compounds confirmed via reference standards.
  • The analysis identified 27 main active compounds with high content, particularly suggesting several as the main pharmacologically active ingredients, laying the groundwork for further research on its clinical applications.

Article Abstract

This study comprehensively analyzed the active components of Sanhan Huashi Formula using qualitative and quantitative mass spectrometry techniques, laying the foundation for understanding its pharmacological substance basis. UHPLC-LTQ-Orbitrap-MS and GC-MS technologies were used to analyze and identify the volatile and non-volatile components in Sanhan Huashi Formula. UHPLC-QQQ-MS/MS technology was used to simultaneously determine the content of 27 major active components in the formula. The results showed that 308 major chemical components were identified in Sanhan Huashi Formula, among which 60 compounds were identified by comparing with reference standards, mainly including alkaloids, flavonoids, coumarins, triterpenoid saponins, amino acids, and nucleosides. GC-MS technology preliminarily identified 52 volatile compounds, with γ-eudesmol and β-eudesmol as the main components. The quantitative results demonstrated good linearity(r>0.99) for the 27 active components, indicating the stability, simplicity, and reliability of the established method. Among them, amygdalin, nodakenin, arecoline, ephedrine, and pseudoephedrine had relatively high content and were presumably the main pharmacologically active substances. In conclusion, this study systematically and comprehensively characterized the major chemical components and patterns in Sanhan Huashi Formula, providing a basis for understanding its pharmacological mechanisms and clinical applications.

Download full-text PDF

Source
http://dx.doi.org/10.19540/j.cnki.cjcmm.20230614.303DOI Listing

Publication Analysis

Top Keywords

sanhan huashi
20
huashi formula
20
active components
12
uhplc-ltq-orbitrap-ms gc-ms
8
components sanhan
8
understanding pharmacological
8
major chemical
8
chemical components
8
components
7
formula
6

Similar Publications

Effectiveness and safety of Sanhan Huashi granules versus nirmatrelvir-ritonavir in adult patients with COVID-19: A randomized, open-label, multicenter trial.

Sci Bull (Beijing)

June 2024

National Center for Respiratory Medicine; State Key Laboratory of Respiratory Health and Multimorbidity; National Clinical Research Center for Respiratory Diseases; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address:

Sanhan Huashi granules (SHG) demonstrated therapeutic effects against coronavirus disease 2019 (COVID-19) in observational studies. In order to compare the effectiveness and safety of SHG and nirmatrelvir-ritonavir in treating adults with mild-to-moderate COVID-19, we conducted a randomized, active-controlled, open-label, multi-center trial conducted between February and July in 2023. The patients were randomized in a 1:1 ratio to the SHG group and the nirmatrelvir-ritonavir group.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the Sanhan Huashi Formula's active components using advanced mass spectrometry techniques, helping to understand its pharmacological basis.
  • 308 major chemical components were identified, including key groups like alkaloids and flavonoids, with 60 compounds confirmed via reference standards.
  • The analysis identified 27 main active compounds with high content, particularly suggesting several as the main pharmacologically active ingredients, laying the groundwork for further research on its clinical applications.
View Article and Find Full Text PDF

[Component identification and analysis in vivo of Sanhan Huashi formula].

Zhongguo Zhong Yao Za Zhi

April 2023

Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.

Sanhan Huashi formula(SHF) is the intermediate of a newly approved traditional Chinese medicine(TCM) Sanhan Huashi Granules for the treatment of COVID-19 infection. The chemical composition of SHF is complex since it contains 20 single herbal medicines. In this study, UHPLC-Orbitrap Exploris 240 was used to identify the chemical components in SHF and in rat plasma, lung and feces after oral administration of SHF, and heat map was plotted for characterizing the distribution of the chemical components.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!